Positive correlations between tumor uptake on FDG PET and energy expenditure of patients with esophageal cancer
- 21 December 2010
- journal article
- clinical trial
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 25 (4) , 241-246
Abstract
Cancer patients are prone to clinical malnutrition; moreover, the energy expenditure in patients with certain cancers is higher than that in healthy individuals, rendering their nutritional management a challenging issue. We hypothesized that 2-deoxy-2-[18F]fluoro-d-glucose (FDG) uptake on positron emission tomography (PET) may be related to the energy expenditure and analyzed the FDG uptake and energy expenditure in esophageal cancer patients to clarify this. Esophageal cancer patients [n = 13, 10 males and 3 females, age 66.5 ± 8.9 (51–82) years] were evaluated for FDG uptake using PET. The resting energy expenditure (REE) and basal energy expenditure (BEE) were calculated using indirect calorimetry and the Harris–Benedict formula, respectively. Regression analyses were performed to compare the parameters of imaging and energy expenditure. Positive correlations were found between tumor uptake on FDG PET and the parameters of energy expenditure. Among them, the correlations between SUVmax and the ratio of REE to BEE (REE/BEE, r = 0.59; p = 0.035) and between SUVmax and the difference between REE and BEE (REE − BEE, r = 0.58; p = 0.036) were moderate and statistically significant. Further, the correlation between tumor uptake expressed as a percentage (%TU) and REE/BEE was mild (r = 0.51) but not significant (p = 0.07), while that between %TU and REE–BEE was weak (r = 0.42) and not significant (p = 0.15). Significant positive correlations between SUVmax on FDG PET and energy expenditure were noted in our study; we consider that these results may aid in determining the nutritional management for esophageal cancer patients.Keywords
This publication has 17 references indexed in Scilit:
- The clinical application of 18F‐fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancerCancer, 2009
- Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging ProjectJournal of Thoracic Oncology, 2008
- The standardized uptake value for F‐18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survivalCancer, 2007
- Positron Emission Tomography As an Imaging BiomarkerJournal of Clinical Oncology, 2006
- Positron-Emission Tomography and Assessment of Cancer TherapyNew England Journal of Medicine, 2006
- Resting energy expenditure of patients with gynecologic malignancies.Journal of the American College of Nutrition, 1995
- Cytokines, the Acute-Phase Response, and Resting Energy Expenditure in Cachectic Patients with Pancreatic CancerAnnals of Surgery, 1994
- Energy balance in relation to cancer cachexiaClinical Nutrition, 1990
- Prognostic effect of weight loss prior tochemotherapy in cancer patientsThe American Journal of Medicine, 1980
- Metabolic response to injury and illness: estimation of energy and protein needs from indirect calorimetry and nitrogen balanceJournal of Parenteral and Enteral Nutrition, 1979